MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Patients with CVID Could Benefit from New Imaging Technique

By Andrew Deutsch
Posted on 08 Dec 2016
Print article
Image: FDG PET-CT chest imaging in a patient with GLILD - FDG uptake is represented by color intensity (Photo courtesy of S. Jolles, University Hospital of Wales).
Image: FDG PET-CT chest imaging in a patient with GLILD - FDG uptake is represented by color intensity (Photo courtesy of S. Jolles, University Hospital of Wales).
An imaging technique using the tracer FDG (fluorodeoxyglucose) together with PET-CT imaging could be used to help patients with inflammatory complications of immunodeficiency disease.

The new proof of concept study found that FDG PET-CT (Positron Emission Tomography/Computed Tomography) could help assess inflammatory complications of Common Variable Immuno-Deficiency (CVID) and other immunodeficiency diseases and treatments. The study was published in the November 2016 issue of the Clinical & Experimental Immunology journal.

The study was carried out by researchers at the University Hospital of Wales (Wales, UK). The researchers used FDG PET-CT to simultaneously assess anatomical structure and metabolic activity in patients with Granulomatous Lymphocytic Interstitial Lung Disease (GLILD). The technique enables a detailed CT scan to be combined with PET images, as an additional layer. The results showed that FDG PET-CT could provide new insights into GLILD before and after treatment, and could be used for other inflammatory disorders as well.

Lead researcher of the study, Dr. Stephen Jolles, University Hospital of Wales, said, "Patients who develop granulomatous lymphocytic interstitial lung disease (GLILD) as a complication of common variable immunodeficiency often have poorer outcomes. Given the multi-systemic nature of this disease, it is currently difficult for clinicians to accurately monitor and assess the optimal timing of treatment as well as the effect of treatment and its duration. This study is the first time that the imaging technique, FDG PET-CT, has been used to assess the combined lung structure and metabolic activity in a patient with GLILD before and after treatment. The images are striking and enlightening in that they reveal the highly metabolically active multi-systemic nature of the disease. It remains to me amazing the ability of this technique to overlay structure with metabolic functional activity in this way."

Related Links:
University Hospital of Wales

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
PACS Workstation
CHILI Web Viewer
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more